The genetic bases for syndromic and nonsyndromic deafness among Jews

Trends in Molecular Medicine

Volumn 9, Issue 11, 2003, Pages 496-502

  Ben Yosef, Tamar ^a   Friedman, Thomas B ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN; MYOSIN;

ALPORT SYNDROME; CHROMOSOME DELETION; GENE LOCUS; GENE MUTATION; GENETIC SCREENING; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; JEW; KIDNEY FAILURE; NONHUMAN; PERCEPTION DEAFNESS; PHENOTYPE; REVIEW; USHER SYNDROME;

EID: 0344009554     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2003.09.004     Document Type: Review

References (73)

1. Burchard, E.G. et al. (2003) The importance of race and ethnic background in biomedical research and clinical practice. N. Engl. J. Med. 348, 1170-1175
2. Whitlock, M.C. (2002) Genetic drift. In Encyclopedia of Evolution (Pagel, M., ed.), pp. 400-403, Oxford University Press
3. Risch, N. et al. (2003) Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection. Am. J. Hum. Genet. 72, 812-822
4. Zlotogora, J. and Bach, G. (2003) The possibility of a selection process in the Ashkenazi Jewish population. Am. J. Hum. Genet. 73, 438-440
5. Ostrer, H. (2001) A genetic profile of contemporary Jewish populations. Nat. Rev. Genet. 2, 891-898
6. Zlotogora, J. et al. (2000) Molecular basis of Mendelian disorders among Jews. Mol. Genet. Metab. 69, 169-180
7. Morton, N.E. (1991) Genetic epidemiology of hearing impairment. Ann. N. Y. Acad. Sci. 630, 16-31
8. Pennings, R. et al. (2003) A review of progressive phenotypes in nonsyndromic autosomal dominant hearing impairment. Audiolog. Med. 1, 47-55
9. Friedman, T.B. et al. Recent advances in the understanding of syndromic forms of hearing loss. Ear Hear. (in press)
10. Friedman, T.B. and Griffith, A.J. (2003) Human nonsyndromic sensorineural deafness. Annu. Rev. Genomics Hum. Genet. 4, 341-402
11. Kikuchi, T. et al. (2000) Gap junction systems in the mammalian cochlea. Brain Res. Brain Res. Rev. 32, 163-166
12. Willecke, K. et al. (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem. 383, 725-737
13. Bruzzone, R. et al. (1996) Connections with connexins: the molecular basis of direct intercellular signaling. Eur. J. Biochem. 238, 1-27
14. Goodenough, D.A. et al. (1996) Connexins, connexons, and intercellular communication. Annu. Rev. Biochem. 65, 475-502
15. Rabionet, R. et al. (2000) Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins. Hum. Mutat. 16, 190-202
16. Rabionet, R. et al. (2002) Connexin mutations in hearing loss, dermatological and neurological disorders. Trends Mol. Med. 8, 205-212
17. Denoyelle, F. et al. (1997) Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum. Mol. Genet. 6, 2173-2177
18. Estivill, X. et al. (1998) Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 351, 394-398
19. Zelante, L. et al. (1997) Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum. Mol. Genet. 6, 1605-1609
20. Rothrock, C.R. et al. (2003) Connexin 26 35delG does not represent a mutational hotspot. Hum. Genet. 113, 18-23
21. Dong, J. et al. (2001) Nonradioactive detection of the common Connexin 26 167delT and 35delG mutations and frequencies among Ashkenazi Jews. Mol. Genet. Metab, 73, 160-163
22. Lerer, I. et al. (2000) Contribution of connexin 26 mutations to nonsyndromic deafness in Ashkenazi patients and the variable phenotypic effect of the mutation 167delT. Am. J. Med. Genet. 95, 53-56
23. Morell, R.J. et al. (1998) Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N. Engl. J. Med. 339, 1500-1505
24. Sobe, T. et al. (1999) High frequency of the deafness-associated 167delT mutation in the connexin 26 (GJB2) gene in Israeli Ashkenazim. Am. J. Med. Genet. 86, 499-500
25. Kelley, P.M. et al. (1998) Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am. J. Hum. Genet. 62, 792-799
26. Sobe, T. et al. (2000) The prevalence and expression of inherited connexin 26 mutations associated with nonsyndromic hearing loss in the Israeli population. Hum. Genet. 106, 50-57
27. Lerer, I. et al. (2001) A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non-syndromic deafness: a novel founder mutation in Ashkenazi Jews. Hum. Mutat. 18, 460
28. del Castillo, I. et al. (2002) A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N. Engl. J. Med. 346, 243-249
29. Pallares-Ruiz, N. et al. (2002) A large deletion including most of GJB6 in recessive non syndromic deafness: a digenic effect? Eur. J. Hum. Genet. 10, 72-76
30. Sellers, J.R. (1999) Protein Profiles: Myosin, Oxford University Press
31. Ahmed, Z.M. et al. (2003) Mutations of MYO6 are associated with recessive deafness, DFNB37. Am. J. Hum. Genet. 72, 1315-1322
32. Melchionda, S. et al. (2001) MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am. J. Hum. Genet. 69, 635-640
33. Weil, D. et al. (1995) Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 374, 60-61
34. Wang, A. et al. (1998) Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science 280, 1447-1451
35. Donaudy, F. et al. (2003) Multiple mutations of MYO1A, a cochlear-expressed gene, in sensorineural hearing loss. Am. J. Hum. Genet. 72, 1571-1577
36. Walsh, T. et al. (2002) From flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc. Natl. Acad. Sci. U. S. A. 99, 7518-7523
37. Petit, C. (2001) Usher syndrome: from genetics to pathogenesis. Annu. Rev. Genomics Hum. Genet. 2, 271-297
38. Mustapha, M. et al. (2002) A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24-25. Hum. Genet. 110, 348-350
39. Ahmed, Z.M. et al. (2001) Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am. J. Hum. Genet. 69, 25-34
40. Bitner-Glindzicz, M. et al. (2000) A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat. Genet. 26, 56-60
41. Bolz, H. et al. (2001) Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat. Genet. 27, 108-112
42. Bork, J.M. et al. (2001) Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am. J. Hum. Genet. 68, 26-37
43. Verpy, E. et al. (2000) A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat. Genet. 26, 51-55
44. Weil, D. et al. (2003) Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. Hum. Mol. Genet. 12, 463-471
45. Alagramam, K.N. et al. (2001) The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene. Nat. Genet. 27, 99-102
46. Hampton, L.L. et al. (2003) A new spontaneous mutation in the mouse Ames waltzer gene, Pcdh15. Hear. Res. 180, 67-75
47. Alagramam, K.N. et al. (2001) Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum. Mol. Genet. 10, 1709-1718
48. Ben-Yosef, T. et al. (2003) A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome. N. Engl. J. Med. 348, 1664-1670
49. Adato, A. et al. (1997) Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins. Am. J. Hum. Genet. 61, 813-821
50. Hasson, T. et al. (1995) Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc. Natl. Acad. Sci. U. S. A. 92, 9815-9819
51. Self, T. et al. (1998) Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development 125, 557-566
52. Gibbs, D. et al. (2003) Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein. Proc. Natl. Acad. Sci. U. S. A. 100, 6481-6486
53. Levy, G. et al. (1997) Myosin VIIA gene: heterogeneity of the mutations responsible for Usher syndrome type IB. Hum. Mol. Genet. 6, 111-116
54. Weston, M.D. et al. (1996) Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. Am. J. Hum. Genet. 59, 1074-1083
55. van Aarem, A. et al. (1996) Stable and progressive hearing loss in type 2A Usher's syndrome. Ann. Otol. Rhinol. Laryngol. 105, 962-967
56. Reisser, C.F. et al. (2002) Hearing loss in Usher syndrome type II is nonprogressive. Ann. Otol. Rhinol. Laryngol. 111, 1108-1111
57. Eudy, J.D. et al. (1998) Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 280, 1753-1757
58. Weston, M.D. et al. (2000) Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am. J. Hum. Genet. 66, 1199-1210
59. Bhattacharya, G. et al. (2002) Localization and expression of usherin: a novel basement membrane protein defective in people with Usher's syndrome type IIa. Hear. Res. 163, 1-11
60. Adato, A. et al. (2000) Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families. Hum. Mutat. 15, 388
61. Joensuu, T. et al. (2001) Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am. J. Hum. Genet. 69, 673-684
62. Adato, A. et al. (2002) USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses. Eur. J. Hum. Genet. 10, 339-350
63. Fields, R.R. et al. (2002) Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations. Am. J. Hum. Genet. 71, 607-617
64. Pakarinen, L. et al. (1995) Usher's syndrome type 3 in Finland. Laryngoscope 105, 613-617
65. Ness, S.L. et al. Genetic homogeneity and clinical variability among Ashkenazi Jewish individuals with Usher syndrome type III. J. Med. Genet. (in press)
66. Tachibana, M. (2000) Alport syndrome. Adv. Otorhinolaryngol. 56, 19-31
67. Gregory, M.C. et al. (1996) Alport syndrome-clinical phenotypes, incidence, and pathology. Contrib. Nephrol. 117, 1-28
68. Barker, D.F. et al. (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248, 1224-1227
69. Barker, D.F. et al. (1997) Common ancestry of three Ashkenazi-American families with Alport syndrome and COL4A5 R1677Q. Hum. Genet. 99, 681-684
70. Gleeson, M.J. (1984) Alport's syndrome: audiological manifestations and implications. J. Laryngol. Otol. 98, 449-465
71. Rintelmann, W. (1976) Auditory manifestations of Alport's disease syndrome. Trans. Am. Acad. Ophthalmol. Otolaryngol. 82, 375-387
72. Mafong, D.D. et al. (2002) Ocular findings in children with congenital sensorineural hearing loss. Arch. Otolaryngol. Head Neck Surg. 128, 1303-1306
73. Mets, M.B. et al. (2000) Early diagnosis of Usher syndrome in children. Trans. Am. Ophthalmol. Soc. 98, 237-245